Viable virus shedding during SARS-CoV-2 reinfection.
作者信息
Letizia Andrew G, Smith Darci R, Ge Yongchao, Ramos Irene, Sealfon Rachel S G, Goforth Carl, Gonzalez-Reiche Ana S, Vangeti Sindhu, Weir Dawn L, Alshammary Hala, Chen Hua Wei, George Mary-Catherine, Soares-Schanoski Alessandra, Lizewski Rhonda A, Lizewski Stephen E, Marayag Jan, Miller Clare M, Nunez Edgar, Porter Chad K, Ana Ernesto Santa, Schilling Megan, Sugiharto Victor A, Sun Peifang, Termini Michael, van de Guchte Adriana, Troyanskaya Olga G, van Bakel Harm, Sealfon Stuart C
机构信息
Naval Medical Research Center, Silver Spring, MD, USA.
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
出版信息
Lancet Respir Med. 2021 Jul;9(7):e56-e57. doi: 10.1016/S2213-2600(21)00219-8. Epub 2021 May 5.
Abstract
摘要
相似文献
1
Viable virus shedding during SARS-CoV-2 reinfection.新冠病毒再次感染期间的活病毒脱落
Lancet Respir Med. 2021 Jul;9(7):e56-e57. doi: 10.1016/S2213-2600(21)00219-8. Epub 2021 May 5.
2
Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.再次感染或严重急性呼吸综合征冠状病毒 2 型的激活：系统评价。
Front Public Health. 2021 Jun 11;9:663045. doi: 10.3389/fpubh.2021.663045. eCollection 2021.
3
Duration of Viral Nucleic Acid Shedding and Early Reinfection With Severe Respiratory Syndrome Coronavirus 2 in Healthcare Workers and First Responders.医护人员和急救人员中严重呼吸综合征冠状病毒 2 的病毒核酸脱落持续时间和早期再感染。
J Infect Dis. 2021 Dec 1;224(11):1873-1877. doi: 10.1093/infdis/jiab504.
4
Utility of Ct values in differentiating COVID-19 reinfection versus prolonged viral shedding in an immunocompromised patient.CT值在区分免疫功能低下患者的新冠病毒再次感染与病毒长期脱落中的作用。
BMJ Case Rep. 2021 Jul 27;14(7):e243692. doi: 10.1136/bcr-2021-243692.
5
Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature.SARS-CoV-2 再感染 - 文献中 23 例分析。
Infect Dis (Lond). 2021 Jul;53(7):479-485. doi: 10.1080/23744235.2021.1905174. Epub 2021 Apr 13.
6
Testing Positive for SARS-CoV-2 in Two Countries 105 Days Apart.在相隔105天的两个国家新冠病毒检测呈阳性。
Prague Med Rep. 2021;122(3):228-232. doi: 10.14712/23362936.2021.21.
7
First documented reinfection of SARS-COV-2 in second wave from Pakistan.首次从巴基斯坦第二波疫情中记录到 SARS-COV-2 的再感染。
J Ayub Med Coll Abbottabad. 2020 Oct-Dec;32(Suppl 1)(4):S704-S705.
8
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.基因组证据表明巴西出现涉及 Spike 蛋白 E484K 突变的 SARS-CoV-2 再感染。
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.
9
SARS-CoV-2 reinfection: report of two cases in Southeast Brazil.SARS-CoV-2 再感染：巴西东南部两例报告。
Rev Inst Med Trop Sao Paulo. 2021 Jun 18;63:e50. doi: 10.1590/S1678-9946202163050. eCollection 2021.
10
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
引用本文的文献
1
Impact of Prolonged SARS-CoV-2 Viral Shedding on COVID-19 Disease Outcome and Viral Dynamics.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）长期病毒脱落对冠状病毒病2019（COVID-19）疾病结局和病毒动力学的影响
Indian J Microbiol. 2024 Dec;64(4):1416-1424. doi: 10.1007/s12088-024-01238-1. Epub 2024 Mar 27.
2
Silent battles: immune responses in asymptomatic SARS-CoV-2 infection.无声的战斗：无症状 SARS-CoV-2 感染中的免疫反应。
Cell Mol Immunol. 2024 Feb;21(2):159-170. doi: 10.1038/s41423-024-01127-z. Epub 2024 Jan 15.
3
Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern.无症状或有症状的新冠病毒感染加上疫苗接种可增强对关注变异株的适应性免疫力。
iScience. 2022 Oct 21;25(10):105202. doi: 10.1016/j.isci.2022.105202. Epub 2022 Sep 23.
4
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
5
Determining SARS-CoV-2 non-infectivity state-A brief overview.确定 SARS-CoV-2 非感染状态——简要概述。
Front Public Health. 2022 Aug 12;10:934242. doi: 10.3389/fpubh.2022.934242. eCollection 2022.
Zotero 插件